How many institutions held KPTI - KARYOPHARM THERAPEUTICS INC. - Common Stock, $0.0001 per value in Q1 2015?

85 institutional investors reported KPTI - KARYOPHARM THERAPEUTICS INC. - Common Stock, $0.0001 per value for Q1 2015. Use the holders table for investor-level position and value details.

KARYOPHARM THERAPEUTICS INC. - Common Stock, $0.0001 per value (KPTI)

Q: What does CUSIP 48576U106 represent in this 13F holders report?

CUSIP 48576U106 is the security identifier for KPTI - KARYOPHARM THERAPEUTICS INC. - Common Stock, $0.0001 per value used to aggregate holder disclosures.

CUSIP: 48576U106

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class: Equity / Common Stock, $0.0001 per value
Shares outstanding: 19,438,500
Total 13F shares: 20,794,207
Share change: +2,051,820
Total reported value: $636,290,225
Put/Call ratio: 146%
Price per share: $30.61
Number of holders: 85
Value change: +$53,545,677
Number of buys: 64
Number of sells: 25

Quarterly Holders Quick Answers

What is CUSIP 48576U106?
CUSIP 48576U106 identifies KPTI - KARYOPHARM THERAPEUTICS INC. - Common Stock, $0.0001 per value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2015
Previous quarter: Q4 2014

Recent filing periods for CUSIP 48576U106:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of KPTI - KARYOPHARM THERAPEUTICS INC. - Common Stock, $0.0001 per value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	25%	4,905,084	$183,597,000	—	31 Dec 2014	13F
FRANKLIN RESOURCES INC	13F	Company	24%	4,652,759	$174,154,000	—	31 Dec 2014	13F
Foresite Capital Management I, LLC	13F	Company	5.1%	999,275	$37,403,000	—	31 Dec 2014	13F
PFM Health Sciences, LP	13F	Company	4.4%	850,337	$31,828,000	—	31 Dec 2014	13F
BlackRock Fund Advisors	13F	Company	3.9%	765,388	$28,648,000	—	31 Dec 2014	13F
STATE STREET CORP	13F	Company	3.5%	673,646	$25,215,000	—	31 Dec 2014	13F
BLACKROCK ADVISORS LLC	13F	Company	3.1%	607,285	$22,731,000	—	31 Dec 2014	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	2.7%	529,920	$19,835,000	—	31 Dec 2014	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	2.2%	418,680	$15,671,000	—	31 Dec 2014	13F
VANGUARD GROUP INC	13F	Company	2.1%	415,689	$15,559,000	—	31 Dec 2014	13F
Cormorant Asset Management, LP	13F	Company	2%	385,000	$14,411,000	—	31 Dec 2014	13F
S.c.a. Candriam	13F	Individual	1.5%	298,000	$11,154,000	—	31 Dec 2014	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	1.1%	219,078	$8,200,000	—	31 Dec 2014	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	1.1%	216,244	$8,093,000	—	31 Dec 2014	13F
BlackRock Group LTD	13F	Company	1.1%	209,917	$7,857,000	—	31 Dec 2014	13F
GUGGENHEIM CAPITAL LLC	13F	Company	0.97%	189,258	$7,083,000	—	31 Dec 2014	13F
UBS Group AG	13F	Company	0.96%	185,740	$6,952,000	—	31 Dec 2014	13F
TCW GROUP INC	13F	Company	0.86%	168,040	$6,289,000	—	31 Dec 2014	13F
NORTHERN TRUST CORP	13F	Company	0.76%	148,574	$5,562,000	—	31 Dec 2014	13F
Tekla Capital Management LLC	13F	Company	0.71%	137,766	$5,157,000	—	31 Dec 2014	13F
New Leaf Venture Partners, L.L.C.	13F	Company	0.65%	126,687	$4,742,000	—	31 Dec 2014	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.58%	112,300	$4,203,000	—	31 Dec 2014	13F
DEUTSCHE BANK AG\	13F	Company	0.55%	107,540	$4,023,000	—	31 Dec 2014	13F
PointState Capital LP	13F	Company	0.51%	100,000	$3,743,000	—	31 Dec 2014	13F
BAKER BROS. ADVISORS LP	13F	Company	0.48%	94,095	$3,522,000	—	31 Dec 2014	13F
BlackRock Finance, Inc.	13F	Company	0.43%	83,355	$3,121,000	—	31 Dec 2014	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.42%	81,047	$3,034,000	—	31 Dec 2014	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.4%	77,314	$2,893,000	—	31 Dec 2014	13F
TEACHERS ADVISORS, LLC	13F	Company	0.36%	70,134	$2,625,000	—	31 Dec 2014	13F
BlackRock Investment Management, LLC	13F	Company	0.36%	69,374	$2,597,000	—	31 Dec 2014	13F
LORD, ABBETT & CO. LLC	13F	Company	0.36%	69,309	$2,594,000	—	31 Dec 2014	13F
Bank of New York Mellon Corp	13F	Company	0.32%	63,024	$2,359,000	—	31 Dec 2014	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.26%	50,000	$1,872,000	—	31 Dec 2014	13F
JPMORGAN CHASE & CO	13F	Company	0.26%	49,800	$1,864,000	—	31 Dec 2014	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.25%	48,089	$1,800,000	—	31 Dec 2014	13F
MORGAN STANLEY	13F	Company	0.25%	47,811	$1,789,000	—	31 Dec 2014	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.24%	45,900	$1,718,000	—	31 Dec 2014	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.22%	43,704	$1,636,000	—	31 Dec 2014	13F
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC	13F	Company	0.21%	40,624	$1,521,000	—	31 Dec 2014	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.2%	38,765	$1,451,000	—	31 Dec 2014	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.16%	30,980	$1,160,000	—	31 Dec 2014	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.15%	30,000	$1,123,000	—	31 Dec 2014	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.13%	25,137	$941,000	—	31 Dec 2014	13F
ProShare Advisors LLC	13F	Company	0.13%	24,569	$920,000	—	31 Dec 2014	13F
Swiss National Bank	13F	Company	0.1%	19,600	$734,000	—	31 Dec 2014	13F
CREDIT SUISSE AG/	13F	Company	0.09%	18,309	$685,000	—	31 Dec 2014	13F
WOODSTOCK CORP	13F	Company	0.09%	17,512	$655,000	—	31 Dec 2014	13F
Partner Investment Management, L.P.	13F	Company	0.08%	16,399	$614,000	—	31 Dec 2014	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.07%	14,525	$544,000	—	31 Dec 2014	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.06%	12,100	$453,000	—	31 Dec 2014	13F

Institutional Holders of KARYOPHARM THERAPEUTICS INC. - Common Stock, $0.0001 per value (KPTI) as of Q1 2015

As of 31 Mar 2015, KARYOPHARM THERAPEUTICS INC. - Common Stock, $0.0001 per value (KPTI) was held by 85 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,794,207 shares. The largest 10 holders included FMR LLC, FRANKLIN RESOURCES INC, Partner Fund Management, L.P., STATE STREET CORP, Palo Alto Investors, LLC, BlackRock Fund Advisors, Sectoral Asset Management Inc, VANGUARD GROUP INC, Tekla Capital Management LLC, and BlackRock Institutional Trust Company, N.A.. This page lists 85 institutional shareholders reporting positions in this security for the Q1 2015 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2015 vs Q4 2014 Across Filers

Q4 2014 holders

Q1 2015 holders

Holder diff

Investor	Q4 2014 Shares	Q1 2015 Shares	Share Diff	Share Chg %	Q4 2014 Value $	Q1 2015 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.